NCT07542158 2026-04-21
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
Phase 2 Enrolling by invitation
Clinical Trials
8 trialsNCT07284589 2026-04-08
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT01697527 2025-11-24
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
Jonsson Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT06956391 2025-06-04
Ultralow Dose PET Imaging of 18F-FDG Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT04023240 2024-08-12
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
Phase 2 Withdrawn
NCT00375830 2023-12-12
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
Stanford University
Phase 2 Completed
NCT02830880 2020-01-07
FACBC Prostate Therapy Response
Emory University
Phase 2 Completed
NCT00492089 2014-05-09
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed